Target
$97 → $96.66
Current stock research snapshot · 8/23/26 Fresh
MDTMedtronic
Investment conviction●●○○○2 of 5 · current snapshot
Research target$96.66Current stock price target
Investment thesis statusSTRENGTHENEDLast reviewed 8/23/26
Market cap$112.06BSnapshot value · 8/23/26
Research history
See all MDT changes ↗What changed
Thesis status
NEEDS_MORE_DATA → STRENGTHENED
Last reviewed
7/31/26 → 8/23/26
Healthspan taxonomy seed — see taxonomy_path
Medtronic Q1 FY2027 earnings (Aug 2026); pulsed field ablation (Affera/PulseSelect) adoption; Hugo surgical system procedures
Thesis weakens if PFA commoditizes (~80-85% penetration, BSX cut guidance twice), Abbott Volt/FARAWAVE Ultra contest the +8pt share gain, or Hugo RAS stays urology-only without general-surgery clearance. (vault 2026-08)
Neutral — Technical chart analysis and competitor discussion on surgical robots; no strong numbers. [X search Aug 2026]
Snapshot · 8/23/26🟡 Mixed · ins-$0.6M · 13F 15+/10-×0.5 · short↑0.21
Snapshot · 8/23/26